Last 12 quarters of trend data · Healthcare · Medical - Care Facilities
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
| Metric | TTM | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | -0.19 | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | |
| P/S Ratio | 0.01 | 0.16 | 0.17 | 0.25 | 0.37 | 0.34 | 1.15 | 1.28 | 0.92 | 2.07 | — | — | — |
| — | -53.4% | -85.4% | -80.1% | -59.6% | -83.5% | — | — | — | — | — | — | — | |
| P/B Ratio | 0.25 | 0.49 | 0.54 | 0.77 | 1.04 | 0.92 | 4.32 | 2.60 | 1.63 | — | — | — | — |
| — | -47.4% | -87.5% | -70.4% | -36.0% | — | — | — | — | — | — | — | — | |
| P/FCF | — | — | — | 2.98 | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | |
| EV / EBITDA | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | |
| EV / EBIT | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
Syra Health Corp. Class A Common Stock's operating margin was -13.8% in Q3 2025, down 10.5 pp QoQ and up 5.3 pp YoY. The trailing four-quarter average of -16.9% lags the current quarter, suggesting the recent improvement is above-trend. Gross margin expanded 10.8% YoY, indicating pricing power or improving input costs.
| Metric | TTM | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 20.7% | 32.9% | 38.7% | 31.7% | 22.7% | 29.7% | 17.8% | 17.1% | 33.0% | 35.1% | 13.1% | 12.4% | 14.8% |
| — | +10.8% | +117.7% | +85.4% | -31.1% | -15.4% | +35.8% | +38.2% | +122.7% | — | — | — | — | |
| Operating Margin | -47.2% | -13.8% | -3.2% | -25.5% | -25.0% | -19.0% | -70.6% | -82.4% | -55.8% | -21.7% | -80.1% | -65.2% | -30.6% |
| — | +27.7% | +95.4% | +69.1% | +55.2% | +12.2% | +11.8% | -26.4% | -82.7% | — | — | — | — | |
| Net Margin | -47.1% | -13.4% | -3.3% | -25.4% | -25.1% | -18.5% | -70.6% | -82.6% | -56.4% | -22.4% | -82.0% | -66.1% | -31.2% |
| — | +27.8% | +95.4% | +69.2% | +55.4% | +17.3% | +13.9% | -24.9% | -80.8% | — | — | — | — |
| Metric | TTM | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -109.1% | -9.8% | -2.6% | -17.7% | -16.2% | -15.4% | -50.2% | -38.8% | -71.5% | — | — | -247.3% | -86.3% |
| — | +36.5% | +94.8% | +54.4% | +77.3% | — | — | +84.3% | +17.1% | — | — | — | — | |
| ROA | -87.4% | -6.7% | -1.8% | -12.8% | -12.4% | -10.9% | -35.7% | -30.5% | -26.4% | -16.1% | -39.2% | -34.0% | -26.4% |
| — | +38.4% | +95.0% | +58.2% | +52.9% | +32.3% | +8.9% | +10.2% | -0.1% | — | — | — | — | |
| ROIC | -294.7% | -51.0% | -30.3% | -68.9% | -35.3% | -29.8% | -159.7% | -163.7% | -93.4% | -32.8% | -58.7% | -43.4% | — |
| — | -71.5% | +81.0% | +57.9% | +62.3% | +9.3% | -172.3% | -277.4% | — | — | — | — | — |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
The current ratio has weakened 34.2% YoY to 3.05x, tightening the short-term liquidity position.
| Metric | TTM | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.16 | 0.11 | 0.05 | 0.05 | 0.16 | 0.17 | 0.22 | 0.04 | 0.06 | — | — | — | 1.32 |
| — | -38.1% | -79.7% | +39.3% | +154.0% | — | — | — | -95.3% | — | — | — | — | |
| Debt / EBITDA | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | |
| Current Ratio | 5.46 | 3.05 | 3.25 | 2.88 | 5.46 | 4.63 | 3.14 | 4.04 | 5.25 | 0.52 | 0.53 | 1.18 | 0.92 |
| — | -34.2% | +3.6% | -28.6% | +4.0% | +792.0% | +489.4% | +242.1% | +469.4% | — | — | — | — | |
| Quick Ratio | 5.46 | 3.05 | 3.25 | 2.88 | 5.46 | 4.63 | 3.14 | 4.04 | 5.25 | 0.52 | 0.48 | 1.11 | 0.89 |
| — | -34.2% | +3.6% | -28.6% | +4.0% | +792.0% | +558.7% | +262.1% | +488.9% | — | — | — | — | |
| Interest Coverage | -241.34 | — | -16.37 | -146.59 | -90.75 | -189.28 | -372.85 | -354.17 | -106.76 | -24.19 | -41.59 | -67.82 | -50.52 |
| — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 12 years · Updated daily
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorSee our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationCompare performance and metrics against top competitors.
Start ComparisonSyra Health Corp. Class A Common Stock's current P/E is -0.2x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
Syra Health Corp. Class A Common Stock's current operating margin is -47.2%. Margins have been expanding over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking Syra Health Corp. Class A Common Stock's business trajectory between earnings reports.